In following the U.S. Supreme Court’s decisions in Daimlar AG v. Bauman, 134 S. Ct. 746 (2014) and BNSF Railway Company v. Tyrrleo, 137 S. Ct. 1549 (2017) and the Missouri Court’s earlier opinion in State ex rel. Norfolk S. Ry. Co. v. Dolan, 512 S.W. 3d 41 (Mo. En Banc 227), the Missouri Supreme Court has dismissed claims filed in the City of St. Louis by nonresident plaintiffs against Bayer Corp. and several subsidiaries for lack of personal jurisdiction.
The plaintiffs in this case had initiated an action against Bayer in St. Louis City Circuit Court to recover damages for personal injuries they allegedly experienced from their use of Essure, a medical device that Bayer manufactures and distributes. The case named 92 plaintiffs, but only seven were Missouri residents. The remaining 85 plaintiffs are not Missouri residents and do not allege they used Essure in Missouri or that they were injured in the state.
None of the Bayer defendants is incorporated in or has a principal place of business in Missouri; thus, these defendants are not “at home” in Missouri.